Aflac (NYSE:AFL) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings
Aflac (NYSE: AFL) reported Q2 CY2026 revenue of $4.12 billion, down 9.2% year on year and below Wall Street estimates, according to the company. Non-GAAP profit was $1.75 per share, in line with consensus. The article also cites BVPS rising to $60.35 per share over two years and notes the stock fell 1.4% to $124.92 after results.
How this was made
The 30-second read
Why it matters
The quarter’s headline is a 9.2% YoY revenue decline to $4.12B that missed estimates, while non-GAAP EPS of $1.75 was in line, creating a mixed earnings read-through.
Market read
Traders likely focus on whether the revenue decline reflects weakening premium demand versus timing, especially since BVPS growth has recently accelerated but consensus expects BVPS to shrink over the next 12 months.
What to watch
The article cites outlier treatment for investment gains/losses and emphasizes net premiums earned as the key revenue driver; traders should separate underwriting demand from investment/float effects when reassessing the quarter.
Background
Aflac is a supplemental health and life insurer, where investors track net premiums earned and balance-sheet metrics like BVPS alongside EPS.
Ticker impact
Aflac reported Q2 CY2026 revenue of $4.12B, down 9.2% YoY, missing Wall Street expectations while non-GAAP EPS matched consensus.
Likely continued volatility and downside bias until investors get clarity on premium demand trends and BVPS trajectory.
The article provides a concrete revenue miss and notes the stock traded down 1.4% to $124.92 immediately after results, indicating the market reaction was driven by top-line weakness rather than earnings.
Market effects
Reinforces that supplemental insurers are being judged primarily on net premium demand quality, not just EPS stability.
Japan product initiatives are highlighted, but the consolidated revenue decline suggests regional execution may not yet offset demand softness.
Limited spillover beyond the U.S. supplemental insurance peer group given company-specific results.
Counterpoint
BVPS accelerated to $60.35 per share over two years and EPS was in line, so the revenue miss may be temporary or timing-related rather than a structural deterioration.
Key entities
- companyAflac Incorporated
Supplemental insurance provider reporting Q2 CY2026 results with revenue miss and in-line non-GAAP EPS.
- executiveDaniel P. Amos
Chairman and CEO quoted on strategy execution and new Japan product opportunities.
